Nanobiotix S.A. (0QAV.L)

EUR 3.05

(1.5%)

Eps Summary of Nanobiotix S.A.

Nanobiotix S.A.'s latest annual eps in 2023 was -1.08 EUR , up 34.15% from previous year.
Nanobiotix S.A.'s latest quarterly eps in 2024 Q2 was -0.46 EUR , down 0.0% from previous quarter.
Nanobiotix S.A. reported an annual eps of -1.64 EUR in 2022, down -21.48% from previous year.
Nanobiotix S.A. reported an annual eps of -1.35 EUR in 2021, up 2.17% from previous year.
Nanobiotix S.A. reported a quarterly eps of -0.80 EUR for 2023 Q2, down 0.0% from previous quarter.
Nanobiotix S.A. reported a quarterly eps of -0.31 EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Eps Chart of Nanobiotix S.A. (2023 - 2012)

Historical Annual Eps of Nanobiotix S.A. (2023 - 2012)

Year	Eps	Eps Growth
2023	-1.08 EUR	34.15%
2022	-1.64 EUR	-21.48%
2021	-1.35 EUR	2.17%
2020	-1.38 EUR	41.28%
2019	-2.35 EUR	-51.61%
2018	-1.55 EUR	-3.33%
2017	-1.50 EUR	-4.9%
2016	-1.43 EUR	-19.17%
2015	-1.20 EUR	-62.16%
2014	-0.74 EUR	2.63%
2013	-0.76 EUR	-16.92%
2012	-0.65 EUR	0.0%

Year	Eps	Eps Growth
2024 Q2	-0.46 EUR	0.0%
2023 Q2	-0.80 EUR	0.0%
2023 Q4	-0.31 EUR	0.0%
2023 FY	- EUR	34.15%
2022 Q4	-0.88 EUR	0.0%
2022 FY	- EUR	-21.48%
2022 Q2	-0.76 EUR	0.0%
2021 Q4	-0.48 EUR	0.0%
2021 Q2	-0.88 EUR	0.0%
2021 FY	- EUR	2.17%
2020 FY	- EUR	41.28%
2020 Q2	-0.91 EUR	0.0%
2020 Q4	-0.47 EUR	0.0%
2019 Q4	-1.21 EUR	0.0%
2019 Q2	-1.15 EUR	0.0%
2019 FY	- EUR	-51.61%
2018 FY	- EUR	-3.33%
2018 Q4	-0.91 EUR	0.0%
2018 Q2	-0.64 EUR	0.0%
2017 Q2	-0.76 EUR	0.0%
2017 FY	- EUR	-4.9%
2017 Q4	-0.74 EUR	0.0%
2016 Q2	-0.68 EUR	0.0%
2016 FY	- EUR	-19.17%
2016 Q4	-0.75 EUR	0.0%
2015 FY	- EUR	-62.16%
2015 Q4	-0.69 EUR	0.0%
2015 Q2	-0.52 EUR	0.0%
2014 FY	- EUR	2.63%
2014 Q2	-0.35 EUR	0.0%
2014 Q4	-0.39 EUR	0.0%
2013 Q4	-0.36 EUR	0.0%
2013 Q2	-0.40 EUR	0.0%
2013 FY	- EUR	-16.92%
2012 Q3	-0.16 EUR	0.0%
2012 FY	- EUR	0.0%
2012 Q4	-0.16 EUR	0.0%

Peer Eps Comparison of Nanobiotix S.A.

Name	Eps	Eps Difference
Boiron SA	2.06 EUR	152.427%
Laboratorios Farmaceuticos Rovi, S.A.	3.20 EUR	133.75%
Vetoquinol SA	4.70 EUR	122.979%
Valneva SE	-0.73 EUR	-47.945%
AB Science S.A.	-0.20 EUR	-440.0%
PHAXIAM Therapeutics S.A.	-5.00 EUR	78.4%
Vivoryon Therapeutics N.V.	-1.12 EUR	3.571%
BioSenic S.A.	-0.21 EUR	-414.286%
ABIVAX Société Anonyme	-3.43 EUR	68.513%
Formycon AG	4.76 EUR	122.689%